Targeting Neoantigens in Glioblastoma: An Overview of Cancer Immunogenomics and Translational Implications.
作者信息
Johanns Tanner M, Bowman-Kirigin Jay A, Liu Connor, Dunn Gavin P
机构信息
Division of Oncology, Department of Medicine, Washington University School of Medicine, St. Louis, Missouri.
The Alvin J. Siteman Cancer Center at Barnes-Jewish Hospital and Washington Univer-sity School of Medicine, St. Louis, Missouri.
出版信息
Neurosurgery. 2017 Sep 1;64(CN_suppl_1):165-176. doi: 10.1093/neuros/nyx321.
Abstract
摘要
相似文献
1
Targeting Neoantigens in Glioblastoma: An Overview of Cancer Immunogenomics and Translational Implications.靶向胶质母细胞瘤中的新抗原：癌症免疫基因组学概述及转化意义
Neurosurgery. 2017 Sep 1;64(CN_suppl_1):165-176. doi: 10.1093/neuros/nyx321.
2
Detection of neoantigen-specific T cells following a personalized vaccine in a patient with glioblastoma.胶质母细胞瘤患者接种个性化疫苗后新抗原特异性T细胞的检测
Oncoimmunology. 2019 Jan 25;8(4):e1561106. doi: 10.1080/2162402X.2018.1561106. eCollection 2019.
3
Applied Cancer Immunogenomics: Leveraging Neoantigen Discovery in Glioblastoma.应用癌症免疫基因组学：利用胶质母细胞瘤中的新抗原发现
Cancer J. 2017 Mar/Apr;23(2):125-130. doi: 10.1097/PPO.0000000000000247.
4
Endogenous Neoantigen-Specific CD8 T Cells Identified in Two Glioblastoma Models Using a Cancer Immunogenomics Approach.采用癌症免疫基因组学方法在两种脑胶质瘤模型中鉴定内源性新抗原特异性 CD8 T 细胞。
Cancer Immunol Res. 2016 Dec;4(12):1007-1015. doi: 10.1158/2326-6066.CIR-16-0156. Epub 2016 Oct 31.
5
Immunogenomics in personalized cancer treatments.个性化癌症治疗中的免疫基因组学
J Hum Genet. 2021 Sep;66(9):901-907. doi: 10.1038/s10038-021-00950-w. Epub 2021 Jun 30.
6
Treatment of an aggressive orthotopic murine glioblastoma model with combination checkpoint blockade and a multivalent neoantigen vaccine.采用联合检查点阻断和多价新抗原疫苗治疗侵袭性原位小鼠胶质母细胞瘤模型。
Neuro Oncol. 2020 Sep 29;22(9):1276-1288. doi: 10.1093/neuonc/noaa050.
7
Considerations for personalized neoantigen vaccination in Malignant glioma.恶性胶质瘤中个性化新抗原疫苗接种的考量因素。
Adv Drug Deliv Rev. 2022 Jul;186:114312. doi: 10.1016/j.addr.2022.114312. Epub 2022 Apr 26.
8
TSNAD and TSNAdb: The Useful Toolkit for Clinical Application of Tumor-Specific Neoantigens.TSNAD 和 TSNAdb：用于肿瘤特异性新抗原临床应用的有用工具包。
Methods Mol Biol. 2023;2673:167-174. doi: 10.1007/978-1-0716-3239-0_11.
9
In Silico Prediction of Tumor Neoantigens with TIminer.基于 TIminer 的肿瘤新抗原的计算机预测。
Methods Mol Biol. 2020;2120:129-145. doi: 10.1007/978-1-0716-0327-7_9.
10
Genomic prediction of neoantigens: immunogenomics before NGS.新抗原的基因组预测：二代测序之前的免疫基因组学
Nat Rev Genet. 2021 Sep;22(9):550-551. doi: 10.1038/s41576-021-00374-4.
引用本文的文献
1
Strategies for neoantigen screening and immunogenicity validation in cancer immunotherapy (Review).癌症免疫治疗中新抗原筛选及免疫原性验证策略（综述）
Int J Oncol. 2025 Jun;66(6). doi: 10.3892/ijo.2025.5749. Epub 2025 May 9.
2
For whom the T cells troll? Bispecific T-cell engagers in glioblastoma.针对谁的 T 细胞在肆虐？双特异性 T 细胞接合器在神经胶质瘤中的作用。
J Immunother Cancer. 2021 Nov;9(11). doi: 10.1136/jitc-2021-003679.
3
Enhancing T Cell Chemotaxis and Infiltration in Glioblastoma.增强胶质母细胞瘤中的T细胞趋化性和浸润
Cancers (Basel). 2021 Oct 26;13(21):5367. doi: 10.3390/cancers13215367.
4
A Calcium-Related Immune Signature in Prognosis Prediction of Patients With Glioma.一种与钙相关的免疫特征在胶质瘤患者预后预测中的作用
Front Cell Dev Biol. 2021 Sep 28;9:723103. doi: 10.3389/fcell.2021.723103. eCollection 2021.
5
High-Resolution Cartography of the Transcriptome and Methylome Landscapes of Diffuse Gliomas.弥漫性胶质瘤转录组和甲基化组景观的高分辨率图谱
Cancers (Basel). 2021 Jun 26;13(13):3198. doi: 10.3390/cancers13133198.
6
A Comparison Between Chemo-Radiotherapy Combined With Immunotherapy and Chemo-Radiotherapy Alone for the Treatment of Newly Diagnosed Glioblastoma: A Systematic Review and Meta-Analysis.化疗联合免疫疗法与单纯化疗放疗治疗新诊断胶质母细胞瘤的比较：一项系统评价和荟萃分析
Front Oncol. 2021 May 11;11:662302. doi: 10.3389/fonc.2021.662302. eCollection 2021.
7
Emerging immunotherapies for malignant glioma: from immunogenomics to cell therapy.恶性神经胶质瘤的新兴免疫疗法：从免疫基因组学到细胞治疗。
Neuro Oncol. 2020 Oct 14;22(10):1425-1438. doi: 10.1093/neuonc/noaa154.
8
A review of glioblastoma immunotherapy.胶质母细胞瘤的免疫治疗综述。
J Neurooncol. 2021 Jan;151(1):41-53. doi: 10.1007/s11060-020-03448-1. Epub 2020 Apr 6.
9
Immunotherapy Against Gliomas: is the Breakthrough Near?免疫疗法治疗脑胶质瘤：突破近在咫尺？
Drugs. 2019 Nov;79(17):1839-1848. doi: 10.1007/s40265-019-01203-z.
10
Cell Membrane-Coated Magnetic Nanocubes with a Homotypic Targeting Ability Increase Intracellular Temperature due to ROS Scavenging and Act as a Versatile Theranostic System for Glioblastoma Multiforme.具有同型靶向能力的细胞膜包覆磁性纳米立方体能清除 ROS 从而增加细胞内温度，并作为多形性胶质母细胞瘤的多功能治疗诊断系统。
Adv Healthc Mater. 2019 Sep;8(18):e1900612. doi: 10.1002/adhm.201900612. Epub 2019 Aug 7.
本文引用的文献
1
Rindopepimut with temozolomide for patients with newly diagnosed, EGFRvIII-expressing glioblastoma (ACT IV): a randomised, double-blind, international phase 3 trial.里登肽联合替莫唑胺治疗新诊断的表皮生长因子受体VIII 表达型胶质母细胞瘤患者（ACT IV）：一项随机、双盲、国际 III 期试验。
Lancet Oncol. 2017 Oct;18(10):1373-1385. doi: 10.1016/S1470-2045(17)30517-X. Epub 2017 Aug 23.
2
The movers and shapers in immune privilege of the CNS.中枢神经系统免疫特权中的推动者和塑造者。
Nat Immunol. 2017 Feb;18(2):123-131. doi: 10.1038/ni.3666. Epub 2017 Jan 16.
3
Evolution of Neoantigen Landscape during Immune Checkpoint Blockade in Non-Small Cell Lung Cancer.非小细胞肺癌免疫检查点阻断治疗期间新抗原格局的演变
Cancer Discov. 2017 Mar;7(3):264-276. doi: 10.1158/2159-8290.CD-16-0828. Epub 2016 Dec 28.
4
Immune targets and neoantigens for cancer immunotherapy and precision medicine.癌症免疫疗法和精准医学的免疫靶点与新抗原
Cell Res. 2017 Jan;27(1):11-37. doi: 10.1038/cr.2016.155. Epub 2016 Dec 27.
5
T-Cell Transfer Therapy Targeting Mutant KRAS in Cancer.针对癌症中突变型KRAS的T细胞转移疗法。
N Engl J Med. 2016 Dec 8;375(23):2255-2262. doi: 10.1056/NEJMoa1609279.
6
Characterization of the blood brain barrier in pediatric central nervous system neoplasms.小儿中枢神经系统肿瘤中血脑屏障的特征
J Interdiscip Histopathol. 2016;4(2):29-33. doi: 10.5455/jihp.20160623053540.
7
Direct identification of clinically relevant neoepitopes presented on native human melanoma tissue by mass spectrometry.通过质谱直接鉴定天然人黑色素瘤组织上呈现的临床相关新表位。
Nat Commun. 2016 Nov 21;7:13404. doi: 10.1038/ncomms13404.
8
Isolation of T-Cell Receptors Specifically Reactive with Mutated Tumor-Associated Antigens from Tumor-Infiltrating Lymphocytes Based on CD137 Expression.基于CD137表达从肿瘤浸润淋巴细胞中分离与突变肿瘤相关抗原特异性反应的T细胞受体
Clin Cancer Res. 2017 May 15;23(10):2491-2505. doi: 10.1158/1078-0432.CCR-16-2680. Epub 2016 Nov 8.
9
Endogenous Neoantigen-Specific CD8 T Cells Identified in Two Glioblastoma Models Using a Cancer Immunogenomics Approach.采用癌症免疫基因组学方法在两种脑胶质瘤模型中鉴定内源性新抗原特异性 CD8 T 细胞。
Cancer Immunol Res. 2016 Dec;4(12):1007-1015. doi: 10.1158/2326-6066.CIR-16-0156. Epub 2016 Oct 31.
10
Immunogenomics of Hypermutated Glioblastoma: A Patient with Germline POLE Deficiency Treated with Checkpoint Blockade Immunotherapy.高突变胶质母细胞瘤的免疫基因组学：一名患有种系POLE缺陷的患者接受检查点阻断免疫治疗。
Cancer Discov. 2016 Nov;6(11):1230-1236. doi: 10.1158/2159-8290.CD-16-0575. Epub 2016 Sep 28.
Zotero 插件